AtaiBeckley Inc. (ATAI)
NASDAQ: ATAI · Real-Time Price · USD
3.670
-0.090 (-2.39%)
At close: Jan 13, 2026, 4:00 PM EST
3.700
+0.030 (0.82%)
After-hours: Jan 13, 2026, 4:17 PM EST
AtaiBeckley Employees
AtaiBeckley had 54 employees as of December 31, 2024. The number of employees decreased by 29 or -34.94% compared to the previous year.
Employees
54
Change (1Y)
-29
Growth (1Y)
-34.94%
Revenue / Employee
$55,889
Profits / Employee
-$2,855,407
Market Cap
1.33B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 54 | -29 | -34.94% |
| Dec 31, 2023 | 83 | -50 | -37.59% |
| Dec 31, 2022 | 133 | 46 | 52.87% |
| Dec 31, 2021 | 87 | 52 | 148.57% |
| Dec 31, 2020 | 35 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ATAI News
- 5 days ago - AtaiBeckley Provides Update and Outlook for 2026 Ahead of J.P. Morgan Healthcare Conference - GlobeNewsWire
- 21 days ago - AtaiBeckley Added to the Nasdaq Biotechnology Index (NBI) - GlobeNewsWire
- 7 weeks ago - Enhanced Fortifies Executive Leadership Team & Board of Directors - PRNewsWire
- 2 months ago - Atai Beckley N.V. (ATAI) Discusses BPL-003 Phase IIb Open-Label Extension Study Results in Treatment Resistant Depression Transcript - Seeking Alpha
- 3 months ago - atai Life Sciences Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Common Shares - GlobeNewsWire
- 3 months ago - Atai Life Sciences And Beckley Psytech: Promising Emerging Leader In Psychedelics - Seeking Alpha
- 3 months ago - atai Life Sciences Announces Pricing of Public Offering of Common Shares - GlobeNewsWire
- 3 months ago - atai Life Sciences Announces Proposed Public Offering of Common Shares - GlobeNewsWire